Gender differences in pain modulation by diffuse noxious inhibitory controls: a systematic review
- PMID: 20557999
- DOI: 10.1016/j.pain.2010.05.013
Gender differences in pain modulation by diffuse noxious inhibitory controls: a systematic review
Erratum in
- Pain. 2010 Nov;151(2):558
Abstract
Over the last decade, extensive research has demonstrated sex differences in pain perception and modulation. Several factors have been proposed to account for the differences observed between men and women, including pain modulation through diffuse noxious inhibitory controls (DNIC). Studies investigating sex differences in DNIC have shown mixed results, with some reporting decreased DNIC effect in women compared with men, while others found no difference in DNIC between the sexes. Additional studies have investigated DNIC in both sexes without focusing on sex differences. This systematic review aimed to answer the following question: "In humans of reproductive age without chronic pain, are women more likely than men to have decreased Diffuse Noxious Inhibitory Controls?" Relevant studies were identified by computerized searches of Pubmed/Medline, Embase, Biosis, Web of Science, PsycInfo and Cochrane (from January 1980 through February 2009). The search was limited to human studies with no language restriction. The initial search identified 718 titles and abstracts. Seventeen studies were included in the final stage and data regarding age and gender of participants, methodology and outcome measurements were extracted and analyzed. The majority of studies using pain report as the outcome found significantly more efficient DNIC in males than females (mean female/male ratio=0.54). Studies evaluating pain thresholds and nociceptive flexion reflex indicated the opposite when simply averaged across studies; however, weighted analyses of threshold found more efficient DNIC in males. Gender differences in DNIC effect depend on both the experimental methodology and the modes of measurement of the effect.
Copyright (c) 2010 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Eliciting adverse effects data from participants in clinical trials.Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2. Cochrane Database Syst Rev. 2018. PMID: 29372930 Free PMC article.
-
Selenium for preventing cancer.Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195. doi: 10.1002/14651858.CD005195.pub4. Cochrane Database Syst Rev. 2018. PMID: 29376219 Free PMC article.
-
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2. Cochrane Database Syst Rev. 2017. PMID: 28535331 Free PMC article.
Cited by
-
Clinical Phenotyping of Youth With New-Onset Musculoskeletal Pain: A Controlled Cohort Study.Clin J Pain. 2017 Jan;33(1):28-36. doi: 10.1097/AJP.0000000000000371. Clin J Pain. 2017. PMID: 27340913 Free PMC article. Clinical Trial.
-
Pain characteristics in medication-related osteonecrosis of the jaws.Support Care Cancer. 2021 Feb;29(2):1073-1080. doi: 10.1007/s00520-020-05600-z. Epub 2020 Jun 29. Support Care Cancer. 2021. PMID: 32601851
-
Chronic pain and sex-differences; women accept and move, while men feel blue.PLoS One. 2017 Apr 25;12(4):e0175737. doi: 10.1371/journal.pone.0175737. eCollection 2017. PLoS One. 2017. PMID: 28441403 Free PMC article.
-
Hormonal influences on thermotactile threshold, pain perception threshold and tolerance: A digital thermoaesthesiometer study.J Family Med Prim Care. 2025 May;14(5):1896-1903. doi: 10.4103/jfmpc.jfmpc_1847_24. Epub 2025 May 31. J Family Med Prim Care. 2025. PMID: 40547726 Free PMC article.
-
Diffuse noxious inhibitory controls and brain networks are modulated in a testosterone-dependent manner in Sprague Dawley rats.Behav Brain Res. 2018 Sep 3;349:91-97. doi: 10.1016/j.bbr.2018.04.055. Epub 2018 May 4. Behav Brain Res. 2018. PMID: 29733874 Free PMC article.
References
-
- al'Absi M, Wittmers LE, Ellestad D, Nordehn G, Kim SW, Kirschbaum C, Grant JE. Sex differences in pain and hypothalamic–pituitary–adrenocortical responses to opioid blockade. Psychosom Med. 2004;66:198-206.
-
- Arendt-Nielsen L, Sluka KA, Nie HL. Experimental muscle pain impairs descending inhibition. Pain. 2008;140:465-471.
-
- Baad-Hansen L, Poulsen HF, Jensen HM, Svensson P. Lack of sex differences in modulation of experimental intraoral pain by diffuse noxious inhibitory controls. Pain. 2005;116:359-365.
-
- Beeson P. Age and sex association of 40 autoimmune diseases. Am J Med. 1994;96:457-462.
-
- Campbell C, France C, Robinson M, Logan H, Geffken G, Fillingim R. Ethnic differences in diffuse noxious inhibitory controls (DNIC). J Pain. 2008;9:759-766.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical